Form 4: Zura Bio Executive Vice President Kiran Nistala Acquires Shares in Private Placement
SEC Form 4 Filing
Kiran Nistala, Executive Vice President of Zura Bio Ltd, acquired 3,195 Class A ordinary shares through a private placement at $3.13 per share on April 22, 2024.
Summary
- On April 22, 2024, Kiran Nistala, Executive Vice President of Zura Bio Ltd, acquired 3,195 Class A ordinary shares.
- The shares were purchased through a private placement transaction.
- The purchase price was $3.13 per share, as per the Securities Purchase Agreement dated April 18, 2024.
- Following the transaction, Mr. Nistala directly owns 3,195 Class A ordinary shares.
Sentiment
Score: 6
Explanation: Neutral sentiment as it reflects a routine transaction. The insider purchase could be seen as a positive signal, but it's a relatively small transaction.
Positives
- An executive's investment in the company may signal confidence in its future prospects.
Industry Context
Insider transactions are closely monitored as they can provide insights into a company's prospects, although they don't always indicate a definitive trend.
Stakeholder Impact
- The transaction could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 04/18/2024 | Date of the Securities Purchase Agreement between Zura Bio Ltd and Kiran Nistala. |
| 04/22/2024 | Date of the transaction where Kiran Nistala acquired 3,195 Class A ordinary shares. |
| 04/24/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.